COAs, Labels, and Product Claims That Keep Hemp Accounts Open

The short answer

Hemp product compliance for payments depends heavily on three things a processor or acquirer can independently verify: a current certificate of analysis for each product, labels that match what the COA actually shows, and marketing claims that do not promise medical benefits the product cannot substantiate. Gaps in any of these are among the most common reasons hemp merchant accounts are flagged or closed.

A COA that is expired, tests a different batch than what is currently shipping, or shows a delta-9 THC level inconsistent with the label creates exposure a payments provider cannot ignore, because it ties directly to legality of the product itself, not just how it is sold.

Keeping a hemp account open over time is less about a one-time approval and more about maintaining a document trail that stays current as formulations, suppliers, and batches change.

What a COA actually needs to show

A certificate of analysis should confirm cannabinoid content including total THC calculated in a way that reflects potential conversion, confirm the product falls under the applicable legal threshold, and ideally include contaminant testing such as pesticides, heavy metals, and microbials depending on the product type.

The COA needs to match the specific batch or lot currently being sold, not an older formulation. Processors reviewing hemp accounts increasingly ask for a COA per SKU and expect it refreshed when the formulation, supplier, or growing season changes, since an outdated COA is functionally the same as having none.

• Confirm total THC, not just delta-9, aligns with the applicable legal limit.
• Match the COA date and batch number to what is actually shipping.
• Keep contaminant testing current for the product category.
• Store COAs somewhere a provider can access quickly on request.

Labels and claims that create risk

Labels need to reflect the COA accurately, including cannabinoid content and any per-serving dosing claims. A label that overstates potency, or that omits information required by the state where the product ships, is a mismatch a reviewer can find quickly and will treat as a red flag regardless of intent.

Marketing claims are a separate and often larger problem. Language suggesting a product treats, cures, or prevents a medical condition pushes the product toward drug-claim territory that most payment providers will not support, and that risk extends across the website, packaging, and any social media the provider reviews as part of underwriting or ongoing monitoring.

• Avoid disease or symptom claims anywhere the provider might review, including social media.
• Ensure per-serving milligram claims on the label match COA results.
• Keep website copy consistent with label copy, mismatches read as inconsistency.

Building a maintenance routine

Treat COA and label management as an ongoing operational task, not a one-time compliance project completed before launch. Assign someone to track expiry dates, batch changes, and supplier switches, and to update the document pack shared with your payments provider whenever something changes.

When a provider requests a document refresh, respond quickly and completely rather than piecemeal. A slow or partial response to a routine request is itself a signal that gets logged, and repeated slow responses can affect how an account is treated during future reviews even if nothing else changed.

Illustrative Example: a hemp brand catching a mismatch before review

A generic hemp edibles brand switched extract suppliers to manage cost, and the new supplier's COA showed a slightly different total THC calculation method than the previous one. The brand's compliance lead caught the discrepancy during a routine internal audit, noticed the label still referenced the old supplier's numbers, and paused sales of the affected batch until updated labels were printed and the new COA was filed.

When the payments provider ran its scheduled document refresh a few weeks later, the brand had already reconciled the label and COA and could show the internal audit trail explaining the transition. The account continued without incident, and the brand adopted a rule requiring COA and label review any time a supplier changed.

The regulatory backdrop

Hemp product compliance for payments sits on top of a legal framework that varies by state and continues to change, including differing thresholds for total THC, different labelling requirements, and different rules on which cannabinoids are permitted for sale at all. Some states restrict or ban certain hemp-derived cannabinoids that are legal elsewhere, and that list has shifted multiple times in recent years.

Rules differ by state and change, so confirm current requirements with your regulator and counsel before finalizing labels or claims for a new market, and revisit that confirmation whenever you expand distribution or reformulate a product rather than assuming an earlier legal review still holds.

Common questions

Quick answers to the questions operators and finance staff raise most often on this topic.

• How often should a COA be refreshed? Whenever the batch, formulation, or supplier changes, and independent of that, on whatever cadence your payments provider or state requires, since both timelines can trigger a refresh separately.
• Does a good COA guarantee my account stays open? No, a current and accurate COA removes one major risk factor but does not offset problems elsewhere such as chargeback rates or marketing claims that overreach what the product can substantiate.
• Can I use the same COA across multiple flavours of the same product? Only if the underlying formulation and cannabinoid content are genuinely identical; different flavours with different extract ratios need their own testing.
• What is the fastest way to lose a hemp account over documentation? Letting a provider discover an expired or mismatched COA during their own review rather than disclosing and correcting it proactively, since that reads as neglect even when it was an oversight.